Echocardiography
Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: A comparison with magnetic resonance imaging

https://doi.org/10.1016/j.jacc.2004.05.068Get rights and content
Under an Elsevier user license
open archive

Objectives

We evaluated the accuracy and reproducibility of contrast echocardiography versus tissue harmonic imaging for measurements of left ventricular (LV) volumes and ejection fraction (EF) compared to magnetic resonance imaging (MRI).

Methods

Digital echo recordings of apical LV views before and after intravenous contrast were collected from 110 consecutive patients. Magnetic resonance imaging of multiple short-axis LV sections was performed with a 1.5-T scanner. Left ventricular volumes and EF were calculated offline by method of discs. Thirty randomly selected patients were reanalyzed for intraobserver and interobserver variability.

Results

Compared with baseline, contrast echo increased feasibility for single-plane and biplane volume analysis from 87% to 100% and from 79% to 95%, respectively. The Bland-Altman analysis demonstrated volume underestimation by echo, but much less pronounced with contrast. Limits of agreement between echo and MRI narrowed significantly with contrast: from −18.1% to 8.3% to −7.7% to 4.1% (EF), from −98.2 to −11.7 ml to −59.0 to 10.7 ml (end-diastolic volume), and from −58.8 to 21.8 ml to −38.6 to 23.9 ml (end-systolic volume). Ejection fraction from precontrast echo and MRI differed by ≥10% (EF units) in 23 patients versus 0 after contrast (p < 0.001). At intraobserver and interobserver analysis, limits of agreement for EF narrowed significantly with contrast.

Conclusions

The two-dimensional echocardiographic evaluation of LV volumes and EF in non-selected cardiac patients was found to be more accurate and reproducible when adding an intravenous contrast agent.

Abbreviations and acronyms

APLAX
apical long-axis
ASE
American Society of Echocardiography
EDV
end-diastolic volume
EF
ejection fraction
ESV
end-systolic volume
LV
left ventricle
LVO
left ventricular opacification
MRI
magnetic resonance imaging
2CH
two-chamber
2D-echo
two-dimensional echocardiography
4CH
four-chamber

Cited by (0)

The study was supported in part by a Research Fellowship grant from the Norwegian Council for Cardiovascular Diseases. Bracco (Italy) and Bristol Myers Squibb (U.S.) provided some of the contrast agent used; GE Vingmed Ultrasound (Norway) provided the research ultrasound machine and software.